Orbit Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.70 M
as on 17-07-2024
- Revenue -10.74%
(FY 2023)
- Profit -27.26%
(FY 2023)
- Ebitda -10.22%
(FY 2023)
- Net Worth 9.68%
(FY 2023)
- Total Assets 16.12%
(FY 2023)
About Orbit Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.70 M.
Dileep Yadav and Mahadev Patil serve as directors at the Company.
- CIN/LLPIN
U51397PN2013PTC148923
- Company No.
148923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Orbit Diagnostics?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dileep Yadav | Director | 25-Sep-2013 | Current |
Mahadev Patil | Director | 25-Sep-2013 | Current |
Financial Performance of Orbit Diagnostics.
Orbit Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.74% decrease. The company also saw a substantial fall in profitability, with a 27.26% decrease in profit. The company's net worth moved up by a moderate rise of 9.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Orbit Diagnostics?
In 2023, Orbit Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kolhapur Life Science Super Speciality Laboratory Private LimitedActive 1 year 8 months
Dileep Yadav and Mahadev Patil are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 26 Mar 2021 | ₹5.00 M | Open |
Axis Bank Limited Creation Date: 24 Sep 2019 | ₹4.70 M | Open |
How Many Employees Work at Orbit Diagnostics?
Orbit Diagnostics has a workforce of 13 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbit Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbit Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.